HIGHLIGHTS
- who: Dan Høgdall from the Department of Oncology, University Hospital, Herlev and Gentofte, Herlev, Denmark have published the research work: Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer, in the Journal: (JOURNAL) of September/23,/2015
- what: Plasma CA 19-9 is the most investigated diagnostic biomarker in BTC with a metaanalysis finding a sensitivity and specificity of 0.72 and 0.84, respectively,31 which is lower than the authors report, but reflective of the decision to categorize all healthy participants as having normal levels . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.